TY - JOUR
T1 - Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern
T2 - Reversal with IL-10
AU - Lúdvíksson, Björn R.
AU - Sneller, Michael C.
AU - Chua, Kevin S.
AU - Talar-Williams, Cheryl
AU - Langford, Carol A.
AU - Ehrhardt, Rolf O.
AU - Fauci, Anthony S.
AU - Strober, Warren
PY - 1998/4/1
Y1 - 1998/4/1
N2 - Wegener's granulomatosis (WG) is a granulomatous vasculitis that affects the upper rspiratory tract, lung, and kidney. Slice T cells make up a significant proportion of cells infiltrating granulomatous lesions in WG, we investigated the proliferative response and cytokine profile of T cells from these patients. PBMs wer isolated from 12 patients with active WG, 7 patients with inactive disease, and 12 healthy normal donors. PBMs from clinically active WG patients exhibited increased proliferation following stimulation with either PMA/lonomycin or anti-CD2 and anti-CD28, when compard with normal donors. In addition, these PBMCs exhibited increased secretion of IFN-γ, but not of IL-4, IL-5, or IL-10. Furthermore, TNF-α production from PBMCs and CD4+ T cells isolated from patients with WG was elevated, when compard with healthy donors. In further studies, we investigated the ability of WG patients' monocytes to produce IL-12 and showed that both inactive and active patients produced increased amounts of IL-12. Finally, the in vitro IFN-γ production by WG PBMC is inhibited in a dose-dependent manner by exogenous IL-10. These data suggest that T cells from WG patients overproduce IFN-γ and TNF-α, probably due to dysregulated IL-12 secretion, and that IL-10 may therefor have therapeutic implications for this disease.
AB - Wegener's granulomatosis (WG) is a granulomatous vasculitis that affects the upper rspiratory tract, lung, and kidney. Slice T cells make up a significant proportion of cells infiltrating granulomatous lesions in WG, we investigated the proliferative response and cytokine profile of T cells from these patients. PBMs wer isolated from 12 patients with active WG, 7 patients with inactive disease, and 12 healthy normal donors. PBMs from clinically active WG patients exhibited increased proliferation following stimulation with either PMA/lonomycin or anti-CD2 and anti-CD28, when compard with normal donors. In addition, these PBMCs exhibited increased secretion of IFN-γ, but not of IL-4, IL-5, or IL-10. Furthermore, TNF-α production from PBMCs and CD4+ T cells isolated from patients with WG was elevated, when compard with healthy donors. In further studies, we investigated the ability of WG patients' monocytes to produce IL-12 and showed that both inactive and active patients produced increased amounts of IL-12. Finally, the in vitro IFN-γ production by WG PBMC is inhibited in a dose-dependent manner by exogenous IL-10. These data suggest that T cells from WG patients overproduce IFN-γ and TNF-α, probably due to dysregulated IL-12 secretion, and that IL-10 may therefor have therapeutic implications for this disease.
UR - http://www.scopus.com/inward/record.url?scp=2642680076&partnerID=8YFLogxK
M3 - Article
C2 - 9531324
AN - SCOPUS:2642680076
SN - 0022-1767
VL - 160
SP - 3602
EP - 3609
JO - Journal of Immunology
JF - Journal of Immunology
IS - 7
ER -